Universal American Financial Rises On Unusually High Volume (UAM)

NEW YORK ( TheStreet) -- Universal American Financial Corporation (NYSE: UAM) is trading at unusually high volume Friday with 1.3 million shares changing hands. It is currently at four times its average daily volume and trading up 69 cents (+7.6%) at $9.79 as of 3:42 p.m. ET.

Universal American Financial has a market cap of $705.7 million and is part of the health care sector and health services industry. Shares are down 55.5% year to date as of the close of trading on Thursday.

Universal American Corp., together with its subsidiaries, provides health insurance and managed care products and services primarily to the senior population in the United States. The company has a P/E ratio of 4.6, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Universal American Financial as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. You can view the full Universal American Financial Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVUP to 95370 or select from multiple alert options.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing